Veriphi Shareholder Update: 7 August 2017

Share Sale. Expressions of interest in in purchasing shares belonging to Kees Klein (Novel Services) has been high. The offer, which expired at 5pm on Friday 4 August, was oversubscribed. Forty-four shareholders expressed interest in acquiring more than 400,000 shares at the discounted price. The 371,864 shares available will be allocated on a prorata basis, for those who have expressed …

Veriphi Shareholder Update: 24 July 2017

ACH Hospital Pharmacy Trials.  Trials at Auckland City Hospital commenced on Saturday 22 July, on 5 oncology drugs. As a first step, we captured preliminary indicative data on each of the drugs, each in a single container, to see how well separated the drug signatures are. The initial data showed good separation between all drugs with less separation between two …

Veriphi Shareholder Update: 16 June 2017

Auckland Hospital Preliminary Trials 100% Successful.  As discussed in our 10 June Update, yesterday we conducted our first blind trials with our new analyser, on 5 anaesthetic drugs and solutions, at Auckland City Hospital Department of Anaesthesia. The purpose of the trials was to assess the impact of transporting our new analyser to a different location and conducting tests in …

Veriphi Shareholder Update: 14 June 2017

Auckland Hospital Research Governance Committee Gives Approval. Further to our Shareholder Update on 10 June, I am writing to let you know that the Auckland Hospital Research Governance Committee has given approval for our hospital trial, on 5 oncology drugs, to proceed.  Testing in preparation for the formal trial starts at the hospital tomorrow. Auckland Hospital Progress.   We anticipate the …